Literature DB >> 6245505

Epstein-Barr virus-induced proteins. III. Analysis of polypeptides from P3HR-1-EBV-superinfected NC37 cells by immunoprecipitation.

N Mueller-Lantzsch, B Georg, N Yamamoto, H zur Hausen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6245505     DOI： 10.1016/0042-6822(80)90087-2

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  11 in total

1.  Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus.

Authors:  B Vroman; J Luka; M Rodriguez; G R Pearson
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

2.  Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells.

Authors:  W King; V Van Santen; E Kieff
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

3.  Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells.

Authors:  M Hummel; E Kieff
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

4.  Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection.

Authors:  M Hummel; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

5.  Filamentous structures associated with Epstein-Barr virus-infected cells.

Authors:  C L Moore; J D Griffith; J E Shaw
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

6.  Effect of the arginine analog canavanine on the synthesis of Epstein-Barr virus-induced proteins in superinfected Raji cells.

Authors:  G J Bayliss; H Wolf
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

7.  Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus.

Authors:  C M Edson; D A Thorley-Lawson
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

8.  Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.

Authors:  G R Pearson; B Vroman; B Chase; T Sculley; M Hummel; E Kieff
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

9.  Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.

Authors:  Yoshifumi Nagata; Hiroko Inoue; Koichi Yamada; Hiroyuki Higashiyama; Kenji Mishima; Yasuhiro Kizu; Ienaka Takeda; Fumio Mizuno; Yoshio Hayashi; Ichiro Saito
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

10.  Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter.

Authors:  J C Lin; M C Smith; J S Pagano
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.